Next, we evaluated the possible involvement of the identified 8 genetic variants in the ACE2 gene in COVID-19 susceptibility by assessing the frequency distribution of each variant among the different BMI groups (Fig. 2), including the symptoms development status, referred as asymptomatic versus symptomatic; (Fig. 3). This evidence concerns the gene ACE2 and COVID-19.